CAM
Cormorant Asset Management’s Kezar Life Sciences KZR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,200,000
| Closed | -$9.92M | – | 77 |
|
|
2022
Q2 | $9.92M | Buy |
+1,200,000
| New | +$9.92M | 0.75% | 40 |
|
|
2020
Q4 | – | Sell |
-931,800
| Closed | -$4.51M | – | 104 |
|
|
2020
Q3 | $4.51M | Sell |
931,800
-368,200
| -28% | -$1.78M | 0.17% | 71 |
|
|
2020
Q2 | $6.73M | Buy |
+1,300,000
| New | +$6.73M | 0.26% | 62 |
|
|
2019
Q4 | – | Sell |
-927,869
| Closed | -$3.04M | – | 69 |
|
|
2019
Q3 | $3.04M | Sell |
927,869
-40,425
| -4% | -$133K | 0.19% | 57 |
|
|
2019
Q2 | $7.47M | Sell |
968,294
-331,706
| -26% | -$2.56M | 0.43% | 51 |
|
|
2019
Q1 | $23.1M | Sell |
1,300,000
-122,911
| -9% | -$2.18M | 1.56% | 24 |
|
|
2018
Q4 | $33.6M | Sell |
1,422,911
-130,000
| -8% | -$3.07M | 2.73% | 10 |
|
|
2018
Q3 | $33.2M | Sell |
1,552,911
-19,999
| -1% | -$428K | 2.16% | 17 |
|
|
2018
Q2 | $27.2M | Buy |
+1,572,910
| New | +$27.2M | 2.01% | 17 |
|